Business profile & competitive position
The Sherwin-Williams Company sits in the Basic Materials sector under the Chemicals - Specialty classification. Its core business is developing, manufacturing, distributing and selling paint, coatings and related products to professional, industrial, commercial and retail customers, with the majority of activity concentrated in North and South America and smaller footprints in the Caribbean, Europe, Asia and Australia. Operations are organized into three segments: the Paint Stores Group, the Consumer Brands Group and the Performance Coatings Group, supported by a centralized Administrative segment that houses the corporate headquarters, R&D center and real estate management.
The company’s physical footprint is significant. The Paint Stores Group operated 4,853 company-owned specialty paint stores as of the most recent disclosure, the Consumer Brands Group operated 307 stores in Latin America, and the Performance Coatings Group had 317 company-operated branches. Roughly 63% of Consumer Brands Group 2025 sales were intersegment transfers, mostly flowing into the Paint Stores Group, which means the retail network is both the largest customer segment and a key internal consolidator of volume.
From a profitability standpoint, Sherwin-Williams reports an 11.0% net margin and a 62.1% return on equity. The wide gap between the two figures is notable: an 11.0% net margin is respectable for a coatings business but does not, on its own, explain a 62.1% ROE. That gap typically points to high asset turnover, meaningful financial leverage, or both, and it is one reason analysts dig into the balance sheet when assessing how sustainable the return is. The large owned-store network does provide distribution scale and brand proximity, but the modest margin also shows that the business is not insulated from input-cost pressure.
Financial posture
With a market capitalization of $80.7 billion and a trailing P/E ratio of 30.3, Sherwin-Williams carries a valuation premium within the Basic Materials space. A P/E in the low-thirties is unusually high for a chemicals/materials producer, and it sits well above what a 11.0% net margin would normally command without additional growth, pricing power or capital-efficiency assumptions embedded in the price.
The 62.1% ROE supports some of that premium, because it signals that management is extracting a large return from the equity base. However, the same metric also warrants scrutiny: when a company in this industry posts an ROE more than five times its net margin, leverage is likely a meaningful contributor. The 1.08 beta indicates the stock has moved slightly more than the broader market on average, which aligns with a highly followed, liquid large-cap materials name rather than a defensive low-volatility holding.
As of the snapshot date, the stock was trading at $332.32, just above its 50-day exponential moving average of $329.24, with an RSI of 55.6. Those technical markers place the price near a neutral-to-slight uptrend posture but carry no directional signal on their own.
Strategic priorities & outlook
The company’s most recent 10-K filing outlines a clear set of near-term operational priorities. In the Consumer Brands Group, capital expenditures are being directed toward environmental compliance, manufacturing capacity expansion, operational efficiencies and maintenance projects at operating sites. That focus is consistent with the October 1, 2026 report that Sherwin-Williams was expanding manufacturing capacity at its Statesville facility.
On the supply side, management is trying to mitigate raw-material and product-sourcing risk through inventory management, strategic supplier relationships, alternative sourcing strategies and long-term manufacturing-capability investments. The filing notes that raw materials make up the majority of consolidated cost of goods sold and that many of those inputs are derived from upstream petrochemical and commodity feedstocks such as propylene.
The company’s human-capital agenda is also listed as a strategic priority, with programs centered on culture, talent acquisition and engagement, occupational health and safety, and total rewards. Specific benefit enhancements include the 2025 backup child-and-elder-care benefit and increased medical-plan discount, with a global well-being program and platform planned for 2026.
Operationally, Sherwin-Williams highlights predictable seasonality: segment sales are traditionally strongest in the second and third quarters, so the firm typically builds inventory in the first quarter and finances the associated working-capital needs with short-term borrowings. Backlog orders are not typically significant, and management believes existing productive capacity is sufficient for 2026.
Macro & geopolitical exposure
As a specialty chemicals and coatings company, Sherwin-Williams is exposed to the full cycle of petrochemical and commodity feedstock costs. Propylene-derived inputs, pigments, resins and solvents are central to paint formulation, so fluctuations in oil and natural-gas prices feed directly into gross margins. Trade policy also matters: tariffs on chemicals, additives or finished coatings can shift both input costs and cross-border competitiveness.
The industry faces ongoing environmental and safety regulation, including volatile organic compound (VOC) limits, chemical disclosure requirements and waste-handling rules. Because Sherwin-Williams operates in Latin America, Europe, Asia and Australia, it also has currency exposure tied to the Mexican peso, Brazilian real, euro, Asian currencies and Australian dollar, which can affect translated revenue and margins.
Demand is cyclically tied to construction, housing turnover, commercial real estate activity and industrial production. Higher interest rates tend to slow residential renovation and new construction, while stronger economic activity boosts both new paint demand and maintenance spending. Weather is also a practical factor: exterior painting volumes concentrate in warmer months, reinforcing the second- and third-quarter sales seasonality called out in the 10-K.
Recent developments
Recent news flow around the stock has been relatively quiet but directionally useful. On October 16, 2026, defenseworld.net reported that First Citizens Bank & Trust Co. acquired 3,483 shares of Sherwin-Williams, a small-capitalization disclosure but one that shows ongoing institutional accumulation. On October 15, 2026, investopedia.com noted that consumer stocks were getting a lift as investors rotated out of technology names, which may have provided a short-term tailwind for a household-recognized name like Sherwin-Williams.
That same day, Seeking Alpha published “Sherwin-Williams: Quality Remains Fairly Priced,” an analytical take suggesting the market has already discounted the company’s quality characteristics at prevailing levels. Earlier, on October 1, 2026, zacks.com reported that Sherwin-Williams was expanding manufacturing capacity at Statesville, matching the 10-K emphasis on capacity and efficiency investments.
Earnings behavior & post-earnings drift
Sherwin-Williams has beaten earnings estimates in six of the last eight reported quarters, for a 75% beat rate. The average earnings surprise across that period is just 0.9%, suggesting the company is meeting expectations more narrowly than the headline beat count alone might imply. The average five-day price move following those earnings releases is -0.75%, classified as a “down” post-earnings drift.
The last four reports illustrate the pattern clearly. On July 28, 2026, Sherwin-Williams reported EPS of $3.70 against a $3.52 estimate, a 5.1% positive surprise, yet the stock fell 2.93% the next day before recovering 2.06% over the following five sessions. On April 28, 2026, EPS of $2.35 beat the $2.27 estimate by 3.5%, but the stock dropped 1.98% the next day and 3.64% over the next five days. On January 29, 2026, EPS of $2.23 beat the $2.16 estimate by 3.2%, producing a flat next-day move of +0.02% and a five-day gain of 1.82%. And on October 28, 2025, EPS of $3.59 beat the $3.45 estimate by 4.1%, but the stock fell 2.46% the next day and 3.24% over the following five days.
In other words, even when the underlying results exceed the official consensus, the stock has often sold off or stalled. That behavior can reflect already elevated expectations, guidance commentary that offsets the beat, or a simple “sell the news” dynamic in a highly covered large cap. The next scheduled earnings release is October 27, 2026, before the market open, with a consensus EPS estimate of $3.69.
Frequently Asked Questions
What does Sherwin-Williams' 62.1% ROE imply about its competitive strength?
The 62.1% ROE is high, but the 11.0% net margin alone does not fully explain it. In a capital-intensive, commodity-linked industry like specialty chemicals, that spread often points to significant financial leverage, strong asset turnover from the owned-store network, or both, so investors typically examine the balance sheet alongside the headline return.
Why does Sherwin-Williams' stock sometimes fall after an earnings beat?
Over the last four quarters, Sherwin-Williams beat consensus EPS every time, yet the next-day reaction was negative in three of those four releases. The average five-day post-earnings drift is -0.75%, which suggests beats are small relative to expectations and that guidance, valuation, or broader sentiment often matters more than the reported number.
What are Sherwin-Williams' key strategic priorities for 2026?
According to its most recent 10-K, priorities include capital spending on environmental compliance, manufacturing-capacity expansion and maintenance in the Consumer Brands Group; managing raw-material and sourcing risk through supplier relationships, alternative sourcing and inventory management; and workforce initiatives such as a 2026 global well-being program and expanded employee benefits.
For a deeper dive into how institutional analysts weigh Sherwin-Williams' valuation, margin trajectory and upcoming earnings setup, consider reviewing the full institutional verdict and consensus notes rather than relying on summary figures alone.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-28 | $3.7 | $3.52 | +5.1% | -2.93% | +2.06% |
| 2026-04-28 | $2.35 | $2.27 | +3.5% | -1.98% | -3.64% |
| 2026-01-29 | $2.23 | $2.16 | +3.2% | +0.02% | +1.82% |
| 2025-10-28 | $3.59 | $3.45 | +4.1% | -2.46% | -3.24% |
| 2025-07-22 | $3.38 | $3.76 | -10.1% | - | - |
| 2025-04-29 | $2.25 | $2.15 | +4.7% | - | - |
Previous SHW editions
Get the institutional verdict on SHW
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the SHW verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.